醫學影像領域的合作與授權協議（2016-2026）

醫學影像領域併購的決定性指標

診斷成像領域的合作關係是由先進的成像技術和整合軟體平台驅動的，其交易結構反映了硬體、數據和臨床工作流程解決方案的結合。

本報告對醫學影像領域的 710 多項合作關係和許可協議進行了全面系統的分析，清楚地展示了夥伴關係在整個市場中的設計、談判和執行方式，並提供了實證支持。

清楚了解市場標準

本報告將使您準確了解醫學影像領域的交易結構，使您能夠：

• 自信地對標類似交易
• 對相關交易中的預付款、里程碑付款和特許權使用費結構進行詳細分析。
• 設定切合實際的市場參數
• 您可以深入了解不同影像方式、軟體整合和合作夥伴概況之間的交易條款差異。
• 支持基於證據的評估和合約結構確定。
• 內部討論應基於實際交易數據，而不是假設。
• 了解大型公司如何處理交易
• 在技​​術整合且根深蒂固的臨床環境中，可視化合作夥伴行為和重複交易結構。
• 全面了解交易結構和執行情況
• 本報告超越了表面的交易數據，提供了對底層合約文件的訪問，從而可以詳細了解實際合約是如何構建的。

這包括：

• 授予和保留的權利
• 負責開發和商業化
• 財務結構和支付觸發機制
• 關鍵合約條款和保障措施
• 這種程度的透明度對於了解醫療影像夥伴關係中價值、風險和控制權的分配至關重要，尤其是當硬體、軟體和資料整合是合作的核心時。
• 專為實際業務發展和策略制定而設計。

本報告主要廣泛用於以下用途：

• 建構和評估基於影像和技術主導的交易
• 在清晰的市場環境下準備談判
• 對平台、軟體和合作夥伴公司進行評估。
• 支援穩健且引人注目的數據驅動型內部策略
• 本報告內容
• 在醫學影像領域達成了超過 710 項合作與授權協議。
• 財務條款，包括預付款、里程碑付款和版稅（如有揭露）。
• 可全文搜尋的合約目錄（依公司、模式和用例）
• 可直接查閱向美國證券交易委員會提交的合約和原始文件。
• 交易趨勢分析、關鍵交易和活躍負責人
• 醫學影像領域交易的可靠、基於證據的參考資料。
• 本報告結合全面的交易報告和合約層面的深入分析，為如何在醫學影像領域建立、談判和評估夥伴關係提供了可靠的、基於證據的指導。

目錄

執行摘要

第1章：引言

第2章：醫學影像交易的發展趨勢

• 介紹
• 在醫學影像處理領域擁有悠久歷史的企業
• 醫療影像產業的大多數活躍相關人員
• 醫學影像相關交易（依交易類型）
• 與診斷影像相關的交易（按治療領域分類）
• 醫療影像相關交易（按行業分類）
• 醫學影像交易相關條款與條件

第3章 診斷影像領域的主要交易

• 介紹
• 醫學影像方面的寶貴資訊。

第4章：醫學影像相關交易中最活躍的相關人員

• 介紹
• 醫療影像產業的大多數活躍相關人員
• 醫療影像產業最活躍公司的公司簡介。

第5章：醫學影像處理合約交易目錄

• 介紹
• 醫學影像處理合約交易目錄

第6章：依技術類型分類的影像診斷處理事務

• 特價優惠列表
• 交易清單 - 診斷影像交易 (AZ)（按公司分類）
• 交易清單 - 醫學影像相關交易（依交易類型）
• 交易清單 - 診斷影像交易（依治療領域分類）
• 交易類型的定義
• 關於這家研究公司
• 當前夥伴關係
• 目前合約
• 理想合作夥伴最新報告的標題

The definitive benchmark for diagnostic imaging dealmaking

Diagnostic imaging partnering is driven by advanced imaging technologies and integrated software platforms, with deal structures reflecting the combination of hardware, data, and clinical workflow solutions.

This report provides a comprehensive and structured analysis of 710+ diagnostic imaging collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

Establish a clear view of market standards

The report enables a precise understanding of how diagnostic imaging deals are structured in practice, allowing you to:

• Benchmark comparable transactions with confidence
• Detailed analysis of upfronts, milestones, and royalty structures across relevant deals
• Define realistic market parameters
• Clear insight into how deal terms vary by imaging modality, software integration, and partner profile
• Support valuation and structuring decisions with evidence
• Ground internal discussions in real transaction data rather than assumptions
• Understand how leading companies approach dealmaking
• Visibility into partner behaviour and recurring deal structures across a technology-integrated and clinically embedded landscape
• Full visibility into deal structure and execution
• Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

• Rights granted and retained
• Development and commercialization responsibilities
• Financial structures and payment triggers
• Key contractual provisions and protections
• This level of transparency is critical to understanding how value, risk, and control are allocated within diagnostic imaging partnerships, particularly where hardware, software, and data integration are central to the collaboration.
• Designed for real-world BD and strategy use

The report is widely used to:

• Structure and benchmark imaging and technology-driven transactions
• Prepare for negotiations with well-defined market context
• Evaluate platform, software, and collaboration partners
• Support internal strategy with robust, defensible data
• What's included
• 710+ diagnostic imaging collaboration and licensing deals
• Financial terms, including upfronts, milestones, and royalties where disclosed
• Fully searchable deal directory (by company, modality, and application)
• Direct access to SEC-filed agreements and source documents
• Analysis of deal trends, key transactions, and active dealmakers
• A trusted, evidence-based reference for diagnostic imaging dealmaking
• Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how diagnostic imaging partnerships are structured, negotiated, and valued.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in diagnostic imaging dealmaking

• 2.1. Introduction
• 2.2. Diagnostic imaging deals over the years
• 2.3. Most active diagnostic imaging dealmakers
• 2.4. Diagnostic imaging deals by deal type
• 2.5. Diagnostic imaging deals by therapy area
• 2.6. Diagnostic imaging deals by industry sector
• 2.7. Deal terms for diagnostic imaging deals
  • 2.7.1 Diagnostic imaging deals headline values
  • 2.7.2 Diagnostic imaging deal upfront payments
  • 2.7.3 Diagnostic imaging deal milestone payments
  • 2.7.4 Diagnostic imaging royalty rates

Chapter 3 - Leading diagnostic imaging deals

• 3.1. Introduction
• 3.2. Top diagnostic imaging deals by value

Chapter 4 - Most active diagnostic imaging dealmakers

• 4.1. Introduction
• 4.2. Most active diagnostic imaging dealmakers
• 4.3. Most active diagnostic imaging deals company profiles

Chapter 5 - Diagnostic imaging contracts dealmaking directory

• 5.1. Introduction
• 5.2. Diagnostic imaging contracts dealmaking directory

Chapter 6 - Diagnostic imaging dealmaking by technology type

• Deal directory
• Deal directory - Diagnostic imaging deals by company A-Z
• Deal directory - Diagnostic imaging deals by deal type
• Deal directory - Diagnostic imaging deals by therapy area
• Deal type definitions
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Diagnostic imaging deals since 2016
• Figure 2: Active diagnostic imaging dealmaking activity since 2016
• Figure 3: Diagnostic imaging deals by deal type since 2016
• Figure 4: Diagnostic imaging deals by therapy area since 2016
• Figure 5: Diagnostic imaging deals by industry sector since 2016
• Figure 6: Diagnostic imaging deals with a headline value
• Figure 7: Diagnostic imaging deals with an upfront value
• Figure 8: Diagnostic imaging deals with a milestone value
• Figure 9: Diagnostic imaging deals with a royalty rate value
• Figure 10: Top diagnostic imaging deals by value since 2016
• Figure 11: Most active diagnostic imaging dealmakers since 2016
• Figure 12: Diagnostic imaging deals by technology type since 2016